AI Verdict
ISBA has stronger fundamentals based on our AI analysis.
ISCO vs ISBA Fundamental Comparison
| Metric | ISCO | ISBA |
|---|---|---|
| Revenue | $6.9M | $96.0M |
| Net Income | $-70,000.0 | $18.9M |
| Net Margin | -1.0% | 19.7% |
| ROE | N/A | 8.2% |
| ROA | -1.3% | 0.9% |
| Current Ratio | 0.80x | N/A |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.01 | $2.56 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ISCO vs ISBA: Frequently Asked Questions
Is ISCO or ISBA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ISBA has stronger fundamentals. ISCO is rated STRONG SELL (92% confidence) while ISBA is rated HOLD (62% confidence). This is not investment advice.
How does ISCO compare to ISBA fundamentally?
International Stem Cell CORP has ROE of N/A vs ISABELLA BANK CORP's 8.2%. Net margins are -1.0% vs 19.7% respectively.
Which stock pays higher dividends, ISCO or ISBA?
ISCO has a dividend yield of N/A or no dividend while ISBA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ISCO or ISBA for long term?
For long-term investing, consider that ISCO has STRONG SELL rating with 92% confidence, while ISBA has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ISCO vs ISBA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ISCO vs ISBA, the AI consensus favors ISBA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.